回到 StockQ 正常版首頁 |
富蘭克林華美中國傘型基金之中國A股基金
| ||||||||||||
年度報酬率 |
2020 | 2021 | 2022 | 2023 | 2024 |
58.12% | -8.30% | -34.45% | -20.28% | 15.31% |
富蘭克林華美中國傘型基金之中國A股基金 基金資料 基金月報 |
日期 | 淨值 | 漲跌比例 |
2025/05/28 | 8.40 | 0.12% |
2025/05/27 | 8.39 | -0.47% |
2025/05/26 | 8.43 | -0.71% |
2025/05/23 | 8.49 | -0.12% |
2025/05/22 | 8.50 | -0.23% |
2025/05/21 | 8.52 | 0.71% |
2025/05/20 | 8.46 | 0.59% |
2025/05/19 | 8.41 | -0.36% |
2025/05/16 | 8.44 | -0.24% |
2025/05/15 | 8.46 | -0.59% |
名稱 | 三個月 | 六個月 | 一年 | 今年 |
富蘭克林華美中國傘型基金之中國A股基金/美元 | -3.34% | -1.06% | -2.44% | -3.00% |
上海綜合指數 | 1.28% | 1.11% | 8.11% | 0.35% |
上海A股指數 | 1.27% | 1.09% | 8.08% | 0.33% |
上海B股指數 | -0.00% | -5.85% | 3.17% | -2.55% |
深圳A股指數 | 10.64% | 7.76% | 24.82% | 5.87% |
深圳B股指數 | 5.71% | 10.87% | 36.76% | 9.83% |
深證成指 | 9.17% | 6.76% | 26.43% | 4.78% |
中小板指指數 | 10.10% | 5.58% | 23.44% | 3.66% |
創業板指指數 | 25.47% | 19.88% | 42.61% | 17.22% |
滬深300指數 | 2.54% | 2.16% | 25.46% | 0.24% |
香港恆生指數 | 2.76% | 21.36% | 27.58% | 17.51% |
香港國企指數 | 1.69% | 23.22% | 30.53% | 17.42% |
香港紅籌指數 | 5.31% | 13.07% | 1.13% | 5.90% |
MSCI 中國指數 (price) | 0.20% | 15.67% | 20.49% | 12.69% |
聯博中國A股基金-A2類型/台幣 | -10.60% | -6.47% | -3.83% | -8.91% |
聯博中國A股基金-A2類型/美元 | -1.90% | 1.71% | 3.43% | -0.20% |
聯博中國A股基金-A2類型/人民幣 | -3.05% | 0.79% | 2.41% | -2.21% |
聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
安聯中國股票基金-A股/配息/美元 | -0.60% | 13.20% | 12.86% | 11.19% |
安聯中國策略基金/台幣 | -12.08% | -7.10% | -0.18% | -8.62% |
霸菱香港中國基金-A類/配息/歐元 | -10.24% | 5.39% | 7.91% | 1.70% |
霸菱香港中國基金-A類/配息/美元 | -2.24% | 13.16% | 12.34% | 10.64% |
霸菱香港中國基金-A類/配息/英鎊 | -8.75% | 6.22% | 6.40% | 2.83% |
貝萊德中國基金A2/美元 | -2.55% | 13.66% | 15.16% | 9.90% |
貝萊德中國基金A2-歐元避險 | -3.32% | 12.14% | 12.24% | 8.42% |
貝萊德中國基金A2-澳幣避險 | -3.63% | 12.16% | 11.97% | 8.23% |
法巴中國股票基金-C股/美元 | -0.94% | 17.92% | 22.75% | 15.99% |
群益華夏盛世基金/台幣 | -13.67% | -7.34% | -8.66% | -10.76% |
群益中國新機會基金/台幣 | -13.29% | -8.85% | -11.33% | -11.06% |
群益中國新機會基金/美元 | -4.76% | -0.85% | -4.54% | -2.50% |
群益華夏盛世基金/美元 | -5.26% | 0.72% | -1.79% | -2.22% |
群益華夏盛世基金/人民幣 | -6.36% | -0.24% | -2.80% | -3.99% |
群益中國新機會基金/人民幣 | -5.86% | -1.79% | -5.51% | -4.26% |
DWS投資中國股票基金A2/美元 | -0.08% | 14.47% | 14.58% | 11.17% |
DWS投資中國股票基金E2/美元 | 0.13% | 14.98% | 15.60% | 11.57% |
DWS投資中國股票基金LC/歐元 | -7.98% | 6.88% | 10.28% | 2.37% |
DWS投資中國股票基金FC/歐元 | -7.80% | 7.31% | 11.16% | 2.70% |
瀚亞中國股票基金/美元 | 0.43% | 15.22% | 15.02% | 12.93% |
瀚亞中國基金/台幣 | -13.26% | -10.92% | -9.02% | -9.59% |
愛德蒙得洛希爾中國基金(A)/歐元 | -10.06% | 4.69% | 19.66% | 2.48% |
愛德蒙得洛希爾中國基金(A)/美元 | -2.04% | 12.31% | 24.98% | 12.24% |
歐義銳榮中國股票基金-R2/美元 | -2.09% | 14.67% | 19.86% | 13.05% |
歐義銳榮中國股票基金-R/歐元 | -10.12% | 6.88% | 14.75% | 3.22% |
富達中國聚焦基金/美元 | 3.08% | 11.26% | 7.10% | 10.18% |
首域盈信中國核心基金/美元 | 0.05% | 7.03% | 5.07% | 5.51% |
富蘭克林華美中國消費基金/台幣 | -10.28% | -6.55% | -6.26% | -8.73% |
富蘭克林華美中國傘型基金之中國A股基金/台幣 | -11.84% | -9.02% | -9.23% | -11.44% |
富蘭克林華美中國傘型基金之中國A股基金/人民幣 | -4.71% | -1.79% | -3.27% | -4.83% |
復華華人世紀基金/台幣 | -0.25% | 1.99% | 9.04% | 0.11% |
復華大中華中小策略基金/台幣 | -12.91% | -14.89% | -10.41% | -16.69% |
匯豐中國動力基金-台幣 | -10.89% | -2.15% | 0.00% | -6.18% |
匯豐中國股票基金AD/美元 | -2.08% | 13.46% | 13.63% | 10.35% |
景順中國基金-A股/美元 | -2.24% | 13.04% | 13.50% | 9.60% |
景順中國基金-A股/歐元對沖 | -2.25% | 12.18% | 10.99% | 8.94% |
景順中國基金-A股/澳幣對沖 | -2.58% | 12.25% | 10.88% | 8.88% |
摩根中國基金-A股/分派/美元 | -0.86% | 11.39% | 14.20% | 9.20% |
木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
木星中國基金–ACC/英鎊 | -2.72% | 15.88% | 27.56% | 9.80% |
野村中國機會基金/台幣 | -14.58% | -1.33% | -9.21% | -5.28% |
鋒裕匯理-中國股票基金-A2/美元 | -1.03% | 13.30% | 12.25% | 11.04% |
鋒裕匯理-中國股票基金-B2/美元 | -1.17% | 12.92% | 11.43% | 10.80% |
鋒裕匯理-中國股票基金-A2/歐元 | -8.96% | 5.78% | 7.92% | 1.75% |
荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
新光中國成長基金/台幣 | -17.97% | -4.83% | -5.01% | -8.19% |
瑞銀(盧森堡)中國精選股票基金/美元 | 4.30% | 16.29% | 13.20% | 14.39% |
瑞銀(盧森堡)中國精選股票基金-月配息/美元 | 3.79% | 15.14% | 10.94% | 13.45% |
元大新中國基金/台幣 | -11.25% | -5.42% | -6.40% | -7.53% |
| ||||||||||||
StockQ 全球股市指數 © All rights reserved.
|